INS and retinal disorder: For insulin-deficient subgroups, including the autoimmune-related and the insulin-deficient clusters, insulin therapy appears to be the treatment of choice, possibly in combination with oral insulin secretagogues, to stabilize long-term blood glucose (HbA1c) and to prevent the development of retinopathy—the most common diabetic complication in these subgroups12.